NCT07634094 Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07597902 SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction Status NOT_YET_RECRUITING Phase PHASE2
NCT07559682 Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07139405 TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy Status NOT_YET_RECRUITING Phase PHASE2
NCT06997068 Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population Status RECRUITING Phase PHASE2
NCT06942039 Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation Status RECRUITING Phase EARLY_PHASE1
NCT06245109 Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis Status RECRUITING Phase PHASE4
NCT02885974 Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE1
NCT01150045 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Status COMPLETED Phase PHASE3
NCT00159484 Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2